BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Advanced Bio-Surfaces, Inc. Announces Initial Experiences Of OrthoGlide(TM) Medial Knee Implant


5/25/2006 2:46:41 PM

MINNEAPOLIS, May 25 /PRNewswire/ -- Advanced Bio-Surfaces, Inc. (ABS), an orthopedic implant developer and manufacturer, announced today the completion of ten OrthoGlide Medial Knee implants in the USA.

"We're excited to report ten patients have received the OrthoGlide implant at sites in the USA," said Dr. Jeff Felt, Chairman and CEO of Advanced Bio- Surfaces. "The availability of the OrthoGlide implant is important to people suffering from osteoarthritis of the knee. Prior to OrthoGlide's clearance to market, patients would have undergone a total knee replacement or other invasive procedure."

One of the first orthopedic surgeons to implant the OrthoGlide Medial Knee Implant in the USA is David Raab, M.D. at Illinois Bone and Joint Institute in Chicago, Illinois. Dr. Raab stated, "Early results show patients are doing well with good pain relief, minimal swelling and near full range of motion." Dr. Raab continued, "Two of my patients have osteoarthritis in their contralateral knee and have already inquired about having the other knee done as well."

Michael Purnell, M.D. practicing at OrthoMed Center in Modesto, California has also completed OrthoGlide implants and shared his thoughts on the implant procedure, "From a surgical standpoint the OrthoGlide is easy to implant, especially when compared to a total knee replacement. In addition, the OrthoGlide required only a small incision and no bone cuts. The OrthoGlide implant procedure, in my opinion, has a positive effect on a patient's chance for a faster recovery time and short length of stay in the hospital. The patients I have implanted have a high level of satisfaction with their initial pain relief."

About Advanced Bio-Surfaces, Inc.

ABS is a privately held company dedicated to the development of innovative joint repair products. The company's first product, the OrthoGlide Medial Knee Implant, is intended for treatment of patients with moderate osteoarthritis of the medial compartment. The company received 510(k) clearance to market from the U.S. Food and Drug Administration (FDA) and CE mark notification from its Notified Body, TUV Product Services (Munich) in February of this year. For additional information contact Robert Siegfried at 952.912.5400.

Advanced Bio-Surfaces, Inc.

CONTACT: Robert Siegfried VP, Finance and Administration, Advanced Bio-Surfaces, Inc., +1-952-912-5400



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES